Emerging Targets of Immunotherapy in Gynecologic Cancer

Although programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA-4) have been successfully applied in the treatment of tumors, their efficiency is still not high enough. New immune targets need to be identified in order to seek alternative tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hongyan, Zong, Liju, Kong, Yujia, Gu, Yu, Yang, Junjun, Xiang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681579/
https://www.ncbi.nlm.nih.gov/pubmed/33239889
http://dx.doi.org/10.2147/OTT.S282530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681579/
https://www.ncbi.nlm.nih.gov/pubmed/33239889
http://dx.doi.org/10.2147/OTT.S282530

Ejemplares similares